Literature DB >> 21856484

In search of new therapeutic targets and strategies for heart failure: recent advances in basic science.

Ajay M Shah1, Douglas L Mann.   

Abstract

Chronic heart failure continues to impose a substantial health-care burden, despite recent treatment advances. The key pathophysiological process that ultimately leads to chronic heart failure is cardiac remodelling in response to chronic disease stresses. Here, we review recent advances in our understanding of molecular and cellular mechanisms that play a part in the complex remodelling process, with a focus on key molecules and pathways that might be suitable targets for therapeutic manipulation. Such pathways include those that regulate cardiac myocyte hypertrophy, calcium homoeostasis, energetics, and cell survival, and processes that take place outside the cardiac myocyte--eg, in the myocardial vasculature and extracellular matrix. We also discuss major gaps in our current understanding, take a critical look at conventional approaches to target discovery that have been used to date, and consider new investigational avenues that might accelerate clinically relevant discovery.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21856484      PMCID: PMC3486638          DOI: 10.1016/S0140-6736(11)60894-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  73 in total

Review 1.  A systematic review of large scale and heterogeneous gene array data in heart failure.

Authors:  Umesh C Sharma; Saraswati Pokharel; Chris T A Evelo; Jos G Maessen
Journal:  J Mol Cell Cardiol       Date:  2005-03       Impact factor: 5.000

Review 2.  The bitter end: the ubiquitin-proteasome system and cardiac dysfunction.

Authors:  Cam Patterson; Christopher Ike; Park W Willis; George A Stouffer; Monte S Willis
Journal:  Circulation       Date:  2007-03-20       Impact factor: 29.690

3.  Control of stress-dependent cardiac growth and gene expression by a microRNA.

Authors:  Eva van Rooij; Lillian B Sutherland; Xiaoxia Qi; James A Richardson; Joseph Hill; Eric N Olson
Journal:  Science       Date:  2007-03-22       Impact factor: 47.728

4.  Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death.

Authors:  Takashi Nakagawa; Shigeomi Shimizu; Tetsuya Watanabe; Osamu Yamaguchi; Kinya Otsu; Hirotaka Yamagata; Hidenori Inohara; Takeshi Kubo; Yoshihide Tsujimoto
Journal:  Nature       Date:  2005-03-31       Impact factor: 49.962

5.  Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes.

Authors:  Anna Zampetaki; Stefan Kiechl; Ignat Drozdov; Peter Willeit; Ursula Mayr; Marianna Prokopi; Agnes Mayr; Siegfried Weger; Friedrich Oberhollenzer; Enzo Bonora; Ajay Shah; Johann Willeit; Manuel Mayr
Journal:  Circ Res       Date:  2010-07-22       Impact factor: 17.367

6.  Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Authors:  Karl Swedberg; Michel Komajda; Michael Böhm; Jeffrey S Borer; Ian Ford; Ariane Dubost-Brama; Guy Lerebours; Luigi Tavazzi
Journal:  Lancet       Date:  2010-09-11       Impact factor: 79.321

7.  Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.

Authors:  Ichiro Shiojima; Kaori Sato; Yasuhiro Izumiya; Stephan Schiekofer; Masahiro Ito; Ronglih Liao; Wilson S Colucci; Kenneth Walsh
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

8.  MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts.

Authors:  Thomas Thum; Carina Gross; Jan Fiedler; Thomas Fischer; Stephan Kissler; Markus Bussen; Paolo Galuppo; Steffen Just; Wolfgang Rottbauer; Stefan Frantz; Mirco Castoldi; Jürgen Soutschek; Victor Koteliansky; Andreas Rosenwald; M Albert Basson; Jonathan D Licht; John T R Pena; Sara H Rouhanifard; Martina U Muckenthaler; Thomas Tuschl; Gail R Martin; Johann Bauersachs; Stefan Engelhardt
Journal:  Nature       Date:  2008-11-30       Impact factor: 49.962

Review 9.  The PPAR trio: regulators of myocardial energy metabolism in health and disease.

Authors:  Jose A Madrazo; Daniel P Kelly
Journal:  J Mol Cell Cardiol       Date:  2008-04-04       Impact factor: 5.000

10.  Cardiac autophagy is a maladaptive response to hemodynamic stress.

Authors:  Hongxin Zhu; Paul Tannous; Janet L Johnstone; Yongli Kong; John M Shelton; James A Richardson; Vien Le; Beth Levine; Beverly A Rothermel; Joseph A Hill
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

View more
  94 in total

1.  Cardiovascular biology: heart fails without pump partner.

Authors:  Sudha K Shenoy; Howard A Rockman
Journal:  Nature       Date:  2011-09-28       Impact factor: 49.962

2.  Therapeutic effects of udenafil on pressure-overload cardiac hypertrophy.

Authors:  Hack-Lyoung Kim; Yong-Jin Kim; Kyung-Hee Kim; Seung-Pyo Lee; Hyung-Kwan Kim; Dae-Won Sohn; Byung-Hee Oh; Young-Bae Park
Journal:  Hypertens Res       Date:  2015-04-02       Impact factor: 3.872

3.  [Change in serum follistatin-like protein 1 and its clinical significance in children with chronic heart failure].

Authors:  Bing-Lu Li; Jin-Dou An; Song Feng; Wei Ge
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2016-02

Review 4.  Epigenetics of the failing heart.

Authors:  José Marín-García; Alexander T Akhmedov
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

5.  Cell-sheet therapy with omentopexy promotes arteriogenesis and improves coronary circulation physiology in failing heart.

Authors:  Satoshi Kainuma; Shigeru Miyagawa; Satsuki Fukushima; James Pearson; Yi Ching Chen; Atsuhiro Saito; Akima Harada; Motoko Shiozaki; Hiroko Iseoka; Tadashi Watabe; Hiroshi Watabe; Genki Horitsugi; Mana Ishibashi; Hayato Ikeda; Hirotsugu Tsuchimochi; Takashi Sonobe; Yutaka Fujii; Hisamichi Naito; Keiji Umetani; Tatsuya Shimizu; Teruo Okano; Eiji Kobayashi; Takashi Daimon; Takayoshi Ueno; Toru Kuratani; Koichi Toda; Nobuyuki Takakura; Jun Hatazawa; Mikiyasu Shirai; Yoshiki Sawa
Journal:  Mol Ther       Date:  2014-11-25       Impact factor: 11.454

6.  United We Stand; Divided We Fibrillate?

Authors:  Barry London
Journal:  Circ Res       Date:  2017-12-08       Impact factor: 17.367

7.  Protein kinase-dependent oxidative regulation of the cardiac Na+-K+ pump: evidence from in vivo and in vitro modulation of cell signalling.

Authors:  Keyvan Karimi Galougahi; Chia-Chi Liu; Alvaro Garcia; Natasha A S Fry; Elisha J Hamilton; Helge H Rasmussen; Gemma A Figtree
Journal:  J Physiol       Date:  2013-04-15       Impact factor: 5.182

8.  Shenfu Injection suppresses inflammation by targeting haptoglobin and pentraxin 3 in rats with chronic ischemic heart failure.

Authors:  Si-Dao Zheng; Hong-Jin Wu; Shao-Ping Yu; Jian-Xun Ren; Wei-Wei Duo; Zeng-Chun Ma; Yue Gao; Sheng-Qi Wang; Yu-Na Liu
Journal:  Chin J Integr Med       Date:  2013-03-15       Impact factor: 1.978

Review 9.  Sympathetic Activation in Chronic Heart Failure: Potential Benefits of Interventional Therapies.

Authors:  Kamila Lachowska; Marcin Gruchała; Krzysztof Narkiewicz; Dagmara Hering
Journal:  Curr Hypertens Rep       Date:  2016-07       Impact factor: 5.369

10.  Hesperetin protects against cardiac remodelling induced by pressure overload in mice.

Authors:  Wei Deng; Duan Jiang; Yi Fang; Heng Zhou; Zhihong Cheng; Yafen Lin; Rui Zhang; Jieyu Zhang; Peng Pu; Yuan Liu; Zhouyan Bian; Qizhu Tang
Journal:  J Mol Histol       Date:  2013-05-30       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.